A comparison between oestrogen and HER-2 immunohistochemical staining of core and excision biopsy specimens in breast cancer

Abstract

Immunohistochemical staining for oestrogen and human epidermal growth factor receptor (HER)-2 is essential in the management of breast cancer patients. Two histological specimens are usually obtained during a breast cancer patient’s treatment: the core biopsy and the final excision specimen.